About Medelec Systems
Medelec Systems offers products and services including Hemostasis OmniView Multiple Band Ligator and OmniTip Ultra EUS Needle.
- SectorsHealthcare
- Legal Name Medelec Systems Pvt. Ltd
- Date of Incorporation 19 Jan, 1983
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹7.93 Cr
FY 2025 · +40% YoY
- Net Profit₹2.55 Cr
FY 2025 · 32% margin
- EBITDA₹4.51 Cr
FY 2025 · 57% margin
Associated legal entities of Medelec Systems
Medelec Systems operates through Medelec Systems Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medelec Systems Private Limited CIN U74899DL1983PTC015032 | Active | 19 Jan 1983 | New Delhi, Delhi | ₹7.9 Cr | – | 2 | View details |
Products & Services of Medelec Systems
Medelec Systems offers a comprehensive portfolio of products and services, including Hemostasis OmniView Multiple Band Ligator and OmniTip Ultra EUS Needle.
This device is used for hemostasis procedures in endoscopy and is manufactured to support medical applications.
This needle is utilized in endoscopic ultrasound procedures and is produced under strict quality controls.
Board of directors of Medelec Systems Private Limited (Medelec Systems)
Medelec Systems Private Limited is the primary company behind Medelec Systems. The board of Medelec Systems Private Limited currently have 2 directors; the longest-serving is Sanjiv Kapur, appointed in 1983. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjiv Kapur DIN 00755441 | Director | 19 Jan 1983 | 43 yrs 8 mo | Medelec Systems Private Limited |
| Nilam Kumari Kapur DIN 00757493 | Director | 19 Jan 1983 | 43 yrs 8 mo | Medelec Systems Private Limited |
Financials of Medelec Systems
Figures of Medelec Systems Private Limited, the primary company behind Medelec Systems, for FY 2025. Revenue was ₹7.93 Cr (+40% year on year). Net profit was ₹2.55 Cr (32% margin). EBITDA was ₹4.51 Cr (57% margin). Revenue has grown at a compounded annual rate of +19% over three years and +10% over five years.
- ₹7.93 CrRevenue · FY 2025 · +40% YoY
- ₹2.55 CrNet profit · 32% margin
- ₹4.51 CrEBITDA · 57% margin
- ₹75,000Paid-up capital
- +19%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Medelec Systems Private Limited are on its company page.
Detailed financial statements for Medelec Systems
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Medelec Systems
10 companies that operate in the same segment as Medelec Systems (Hematology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small activating RNA therapeutics are developed to restore gene function. | 2008 | London, England, United Kingdom | USD 460.41 M | USD 23.07 M | 37 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 442 M | – | 66 | |
Developer of therapeutics for the treatment of hematologic diseases | 2017 | Cambridge, Massachusetts, United States | USD 140 M | – | 84 | |
Gene therapy platform is developed for chronic disease treatments. | 2015 | Stevenage, Hertfordshire, United Kingdom | USD 273.69 M | USD 435.87 K | 152 | |
Novel anticoagulants for thrombosis treatment are developed. | 2019 | Cambridge, Massachusetts, United States | USD 250 M | – | 14 | |
Developer of therapies for treating hemochromatosis & beta thalassemia | 1989 | San Diego, California, United States | – | USD 75.72 M | 71 | |
Breakthrough therapies are developed for blood diseases and infections. | 2014 | Buffalo, New York, United States | USD 1 M | – | 22 | |
Hematology products and solutions are provided for medical applications. | 1971 | Braintree, Massachusetts, United States | – | USD 1.33 B | 3,020 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medelec Systems
The primary company behind Medelec Systems, Medelec Systems Private Limited, reported revenue of ₹7.93 Cr for FY 2025, up 40% year on year.
Medelec Systems Pvt. Ltd. has been involved in the manufacturing of medical devices for endoscopy since 1983, with a history spanning over 25 years. High-quality standards are maintained in the production of products such as band ligators, injection needles, and extraction balloons. Continuous collaboration with the medical community is conducted to ensure that these devices meet and exceed required specifications. The company operates from locations in New Delhi and Bangalore, India, where efforts are focused on providing reliable solutions for healthcare needs. Products like biliary stents and EUS needles are developed to support diagnostic and therapeutic applications in a professional manner.
Medelec Systems offers Hemostasis OmniView Multiple Band Ligator and OmniTip Ultra EUS Needle.
Medelec Systems operates through Medelec Systems Private Limited.
The legal entities of Medelec Systems currently have 2 directors, including Sanjiv Kapur, Nilam Kumari Kapur.